CT and MRI systems have emerged as major growth drivers, particularly in tertiary care hospitals and advanced diagnostic centers. Our premium and mid-range systems are gaining rapid adoption for their clinical accuracy, compact design, and cost-efficiency tailored to Indian healthcare needs. In digital radiography, Fujifilm has established market leadership with our Portable X-ray Unit FDR Xair, which are being deployed extensively in both urban and rural setups.
We have seen strong uptake in government tenders and public – private partnership models, especially for DR and mobile X-ray units supporting national screening programs for TB and noncommunicable diseases. Growth has also been fueled by the localization of our service and support infrastructure, strategic collaborations with healthcare chains and diagnostic partners, the launch of AI-powered solutions across modalities, and focused investments in training and clinician engagement. Looking ahead, our next big bet is on integrating AI diagnostics, portable imaging, and personalized screening to create scalable, value-based care models for India.
Where is the next big bet for FUJIFILM India, AI diagnostics, portable imaging, personalized screening, or something else entirely?
Our next big bet is on the convergence of AI diagnostics, portable imaging, and personalized screening. By combining these, we are creating an integrated ecosystem that ensures timely, accurate, and accessible care. Whether it’ s an FDR X-Air enabling on-the-spot screening in remote villages or AI helping clinicians detect disease earlier, our goal is clear— early detection, faster decisions, and better outcomes across every corner of India.
BioTech
BIOVOICENEWS. COM 31